June 26 (Reuters) - BIOCARTIS GROUP NV BCART.BR :
* US MULTICENTER STUDY SHOWS IDYLLA™ ALLOWS RAPID AND
ACCURATE
MUTATION TESTING RESULTS ACROSS DIFFERENT LABORATORY SETTINGS
* STUDY SHOWS THAT, COMPARED TO CURRENT STANDARD-OF-CARE
TESTING
METHODS, BIOCARTIS' IDYLLA™ CAN SUBSTANTIALLY IMPROVE TURNAROUND
TIME OF RESULTS OF MUTATION TESTING
* RESEARCHERS FOUND THAT AVERAGE TURNAROUND TIME FOR TEST
RESULTS
COULD BE CUT BY MORE THAN 50% FROM 15 DAYS TO 5 DAYS, WITH SOME
RESULTS AVAILABLE IN A SINGLE DAY, WITH IDYLLA
Source text for Eikon: ID:nGNE9DdfpK
Further company coverage: BCART.BR
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))